[F12. A statement describing the types of investigational medicinal product in respect of which the authorisation is required, including their pharmaceutical forms.]U.K.
Textual Amendments
F1Sch. 6 para. 2 substituted (29.8.2006) by The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 (S.I. 2006/1928), regs. 1(1), 31(a)